Dreams are often born through the experiences that challenge and shape us, evolving from moments of personal impact into a ...

Arbutus Biopharma Corporation (Nasdaq: ABUS), (“Arbutus” or the “Company”) a clinical-stage biopharmaceutical company ...

LVS Advisory discusses an investment they made in Medpace in the third quarter of 2024. Click here to read more about their ...

Alzheimer’s disease may damage the brain in two phases, according to new research published in Nature Neuroscience on Monday.

DelveInsight's 'Metastatic Castration-Sensitive Prostate Cancer Pipeline Insight 2024' report provides comprehensive global ...

With the perpetual rise of technology and the proliferation of AI, we are moving faster than ever. New inventions have accelerated nearly every aspect of our lives, including medicine. In 2023, the ...

AI-based clinical simulation systems can be a game-changer for the pharmaceutical industry. The ability to predict clinical ...

Alzheimer’s disease may damage the brain in two distinct phases, based on new research funded by the National Institutes of ...

For the first nine months of 2024, The LVS Growth Portfolio gained 27.1% and the LVS Event-Driven Portfolio gained 4.9%, net ...

Interest in clinical trials is high among members of the LGBTQ community and people of color, though participation rates are ...

University of California San Diego and University of California Berkeley researchers have been awarded up to $7 million from ...

A recent study suggests that a carbohydrate-rich breakfast for men and a fat-rich breakfast for women may be best for ...